عنوان
پدید آورنده
موضوع
رده
RA 401.A1 P43 2007
RA
401
.
A1
P43
2007
کتابخانه
محل استقرار
OTHER STANDARD IDENTIFIER
Standard Number
electronic
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Pharmaceutical innovation :incentives, competition, and cost-benefit analysis in international perspective
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Cambridge ; New York
Name of Publisher, Distributor, etc.
Cambridge University Press
Date of Publication, Distribution, etc.
2007
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
xiv, 331 p. : ill. ; 24 cm
GENERAL NOTES
Text of Note
Includes bibliographical references )p. 293-317( and index
NOTES PERTAINING TO TITLE AND STATEMENT OF RESPONSIBILITY
Text of Note
Frank A. Sloan, Chee-Ruey Hsieh
CONTENTS NOTE
Text of Note
Introduction / Frank A. Sloan and Chee-Ruey Hsieh -- The pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents fail: finding new drugs for the developing world / Stephen M. Maurer -- Implementing a public subsidy for vaccines / Frank A. Sloan and Charles E. Eesley -- Ensuring the future supply of vaccines: is a national vaccine authority the answer? / Frank R. Lichtenberg -- Competition between generic and branded drugs / Henry Grabowski -- The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? / Ernst R. Berndt -- Measures of costs and benefits for drugs in cost-effectiveness analysis / Mark V. Pauly -- Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience / Michael Drummond -- Pharmaceutical spending and health outcomes / Pierre-Yves Cremieux ... ]et al.[ -- Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan / Chee-Ruey Hsieh ... ]et al.[ -- Conclusions and policy implications / Frank A. Sloan and Chee-Ruey Hsieh
TOPICAL NAME USED AS SUBJECT
Entry Element
، Pharmaceutical policy
Entry Element
، Pharmaceutical industry
Entry Element
Technological innovations Economic aspects ، Drug development
Entry Element
economics ، Drug Industry
Entry Element
، Cost-Benefit Analysis
Entry Element
، Economic Competition
Entry Element
، Health Policy
Entry Element
economics ، Pharmaceutical Preparations
Entry Element
economics ، Vaccines
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RA
401
.
A1
P43
2007
PERSONAL NAME - PRIMARY RESPONSIBILITY
Relator Code
TI
AU Sloan, Frank A
AU Hsieh, Chee-Ruey
